The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2016

Filed:

Aug. 10, 2015
Applicant:

Wisconsin Alumni Research Foundation, Madison, WI (US);

Inventors:

Srikumar Sengupta, Madison, WI (US);

James Thomson, Madison, WI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); C12N 5/071 (2010.01); A61K 35/407 (2015.01); A61K 35/545 (2015.01); G01N 33/50 (2006.01); A61K 38/38 (2006.01); A61K 38/44 (2006.01); A61K 38/45 (2006.01); A61K 38/57 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 35/407 (2013.01); A61K 35/545 (2013.01); C12N 5/067 (2013.01); C12N 5/0672 (2013.01); C12N 15/111 (2013.01); G01N 33/5014 (2013.01); A61K 38/38 (2013.01); A61K 38/44 (2013.01); A61K 38/45 (2013.01); A61K 38/57 (2013.01); C12N 2310/141 (2013.01); C12N 2320/30 (2013.01); C12N 2501/65 (2013.01); C12N 2510/00 (2013.01); C12Y 114/13017 (2013.01); C12Y 114/14001 (2013.01); C12Y 206/01005 (2013.01);
Abstract

A method for producing mature hepatocytes having functional hepatic enzyme activity from human pluripotent cells is disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122, the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-let-7c, a microRNA having the seed sequence of the microRNA miR-122, a microRNA having the seed sequence of the microRNA miR-let-7c, or a combination thereof into one or more fetal hepatocytes. The resulting cells differentiate into mature hepatocytes that exhibit functional hepatic enzyme activity, and can be used in drug metabolism and toxicity testing, in the study of viruses that target hepatic tissue, and as therapeutics. A related method of maintaining the functional hepatic enzyme activity of primary hepatocytes over time is also disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122 into one or more cultured primary hepatocytes.


Find Patent Forward Citations

Loading…